Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP244693.RAGuExC6VyKx8dIRecDck1BWGFYbeAUBOs5mIMt5m5O_A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP244693.RAGuExC6VyKx8dIRecDck1BWGFYbeAUBOs5mIMt5m5O_A130_assertion type Assertion NP244693.RAGuExC6VyKx8dIRecDck1BWGFYbeAUBOs5mIMt5m5O_A130_head.
- NP244693.RAGuExC6VyKx8dIRecDck1BWGFYbeAUBOs5mIMt5m5O_A130_assertion description "[The presence of high levels of immunoreactive Apo-D in HGPIN and prostate cancer, but not in non-malignant epithelial cells, is consistent with HGPIN being an intermediate lesion in the transition to prostate cancer, and suggests that cellular Apo-D expression is a marker of malignant transformation of the prostate.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP244693.RAGuExC6VyKx8dIRecDck1BWGFYbeAUBOs5mIMt5m5O_A130_provenance.
- NP244693.RAGuExC6VyKx8dIRecDck1BWGFYbeAUBOs5mIMt5m5O_A130_assertion evidence source_evidence_literature NP244693.RAGuExC6VyKx8dIRecDck1BWGFYbeAUBOs5mIMt5m5O_A130_provenance.
- NP244693.RAGuExC6VyKx8dIRecDck1BWGFYbeAUBOs5mIMt5m5O_A130_assertion SIO_000772 14716735 NP244693.RAGuExC6VyKx8dIRecDck1BWGFYbeAUBOs5mIMt5m5O_A130_provenance.
- NP244693.RAGuExC6VyKx8dIRecDck1BWGFYbeAUBOs5mIMt5m5O_A130_assertion wasDerivedFrom befree-20150227 NP244693.RAGuExC6VyKx8dIRecDck1BWGFYbeAUBOs5mIMt5m5O_A130_provenance.
- NP244693.RAGuExC6VyKx8dIRecDck1BWGFYbeAUBOs5mIMt5m5O_A130_assertion wasGeneratedBy ECO_0000203 NP244693.RAGuExC6VyKx8dIRecDck1BWGFYbeAUBOs5mIMt5m5O_A130_provenance.